FTI Advances issues audit-ready ADE (Acceptable Daily Exposure) certificates for pharmaceutical manufacturers in India and globally. Prepared by qualified toxicologists. Accepted by EMA, FDA, WHO, and CDSCO.
An ADE (Acceptable Daily Exposure) certificate — also referred to in European guidelines as a PDE (Permitted Daily Exposure) report — is a toxicological assessment document establishing the maximum amount of an API that, if present as a residual contaminant in the next product manufactured on the same equipment, would not pose an unacceptable risk to patients.
The ADE/PDE-based approach to cleaning validation was mandated by the EMA in 2014 through Guideline EMA/CHMP/CVMP/SWP/169430/2012, replacing older, arbitrary limits such as the 10 ppm rule or 1/1000th of the minimum therapeutic dose. Today, an ADE certificate India from a qualified toxicologist is required for all pharmaceutical facilities manufacturing multiple products on shared equipment — whether for domestic GMP compliance or export market registration.
India's revised Schedule M now explicitly mandates ADE/HBEL documentation, making it a legally enforceable requirement under the Drugs and Cosmetics Act for domestic manufacturers as well.
The terms ADE and PDE refer to the same concept — a health-based, patient safety-focused exposure limit — but are used by different regulatory bodies. ADE is the preferred terminology under ISPE Risk-MaPP guidance and USFDA cleaning validation guidance. PDE is used in EMA's guideline and is the term most commonly used in European GMP inspections.
FTI Advances issues ADE certificates that satisfy both terminologies simultaneously, with a single document clearly cross-referencing both terms and the applicable regulatory frameworks. This means Indian pharmaceutical companies exporting to both the USA and European markets need only one certificate per molecule from our ADE certificate service in India.
Obtaining an ADE certificate from FTI Advances involves a straightforward process. You submit the API name, CAS number, and any available internal toxicological data. Our qualified toxicologist team conducts a structured literature search across regulatory, clinical, and preclinical databases. The critical effect and point of departure (NOAEL/LOAEL) are identified and documented. All uncertainty factors (F1–F5) are applied with individual scientific justification. The final ADE value is calculated and the certificate is prepared in fully formatted, audit-ready format, signed by the qualified toxicologist.
The complete certificate package includes: the ADE value in mg/day; route-specific PDEs where required (oral, parenteral, inhalation, dermal); a full literature review summary; data tables; uncertainty factor justification; regulatory compliance statements for EMA, FDA, WHO-GMP, and Schedule M; and the toxicologist's credentials and conflict of interest declaration.
ADE certificates are required across a wide range of pharmaceutical manufacturing scenarios in India. Multi-product API manufacturing plants — where different active pharmaceutical ingredients are synthesised or processed on shared reactor trains, filtration equipment, or granulators — must have ADE certificates for all APIs in the product portfolio.
Contract manufacturing organisations (CMOs) accepting campaigns from multiple clients must have ADE certificates for each client's API to demonstrate that their cleaning procedures adequately protect subsequent products. Finished dosage form (FDF) facilities mixing multiple API-containing products on shared tablet presses, capsule filling lines, or coating pans require ADE-based cleaning limits for each product.
WHO-GMP prequalified facilities, EMA-approved manufacturing sites, and any Indian facility subject to USFDA inspection must have ADE certificates as part of their cleaning validation master plan. CDSCO auditors under revised Schedule M now also verify these documents during domestic GMP inspections.
One of the key advantages of sourcing your ADE certificate India from FTI Advances is the combination of world-class scientific quality at Indian CRO pricing. European and US-based toxicology consultants charge significantly higher rates for equivalent reports, making India-based ADE certificate services an attractive option for both Indian domestic manufacturers and global pharmaceutical companies looking to reduce their HBEL compliance costs.
FTI Advances offers transparent, upfront pricing with no hidden charges. Bulk discounts are available for facilities requiring ADE certificates for 10 or more APIs simultaneously. We also offer an annual subscription model for facilities with ongoing new product introduction requirements.
ADE certificates do not have a fixed expiry date, but regulatory agencies — particularly EMA — require periodic review of HBEL assessments when new toxicological data becomes available or at intervals not exceeding three years (per EMA Q&A 2018). FTI Advances provides periodic review services to keep your ADE certificates current, updated with any new regulatory guidance or published toxicological literature relevant to your API.
We also provide post-issuance support for regulatory queries — if an EMA or USFDA inspector questions an aspect of your ADE certificate during a GMP inspection, our qualified toxicologist team provides written scientific responses and, where necessary, supplementary data packages to defend the assessed value.
Beyond the ADE certificate India itself, FTI Advances provides comprehensive ADE calculation india support to help pharmaceutical manufacturers implement health-based cleaning limits across their entire product portfolio. Our services cover ADE PDE toxicologist assessment for all API types — small molecules, peptides, biologics, hormones, cytotoxics, and novel chemical entities. We also perform cleaning validation toxicology consulting to help your QA team translate ADE values into practical swab and rinse water limits.
For Indian companies targeting WHO prequalification or entering regulated export markets for the first time, our ADE certificate India service provides a fast, cost-effective pathway to cleaning validation compliance. We have helped numerous Indian pharmaceutical manufacturers prepare for their first EMA GMP inspection or USFDA pre-approval inspection (PAI) by establishing complete ADE documentation packages for all products manufactured at their facility.
FTI Advances also offers ADE report USA pharma compatible reports and outsource PDE calculation Europe services — making our India-based team a one-stop solution for global pharmaceutical companies seeking to reduce their HBEL compliance costs without compromising regulatory quality. Contact us to discuss your ADE calculation india requirements and receive a no-obligation quotation.
Obtaining an ADE certificate is a straightforward process when you work with the right provider — but the quality of the document matters enormously. Regulatory inspectors from EMA, USFDA, WHO, and CDSCO are experienced at identifying reports that lack rigour: missing uncertainty factor justifications, literature searches limited to a single database, or the absence of a named, credentialed toxicologist. An ADE certificate in India from FTI Advances eliminates every one of these risks. Every report we issue is grounded in a systematic, multi-database literature review, prepared and signed by a qualified toxicologist whose credentials are fully documented, and structured to satisfy the audit expectations of all major regulatory agencies simultaneously.
Many pharmaceutical companies discover the limitations of their existing HBEL documentation only when a regulatory inspector raises a critical observation. The most frequent deficiencies include: using an outdated PDE value from a secondary source without verifying the originating methodology; applying incorrect uncertainty factors for route or species extrapolation; and failing to document the scientific rationale clearly enough for a non-specialist inspector to follow. When FTI Advances issues an ADE certificate for Indian pharmaceutical manufacturers, the report is built to anticipate these questions — every decision is explained, every data point is referenced, and the uncertainty factor table is presented in a format that satisfies EMA, FDA, and WHO-GMP inspectors without requiring supplementary explanation.
Commissioning an ADE certificate from FTI Advances in India is designed to be as simple as possible for your team. You provide the API name, CAS number, primary indication, and route of administration — and our qualified toxicologists handle the full assessment. Standard delivery is five to seven business days, with the completed certificate provided in both PDF and editable Word format for integration into your cleaning validation master plan. For facilities managing large product portfolios, our bulk assessment packages offer tiered pricing and dedicated project management, ensuring that your entire molecule catalogue is covered well ahead of your next regulatory inspection deadline.
Submit your API today. ADE certificates delivered in 5–7 business days by qualified toxicologists. Accepted by EMA, FDA, CDSCO, and WHO inspectors.
Request ADE Certificate →Complete acceptable daily exposure certification from India's qualified toxicologist team.
Formal ADE certificate signed by qualified toxicologist — audit-ready format for EMA, FDA, and CDSCO inspections.
PDE calculation per EMA Guideline EMA/CHMP/CVMP/SWP/169430/2012 for European market compliance.
Maximum allowable carryover calculations derived from your ADE value — direct input for cleaning validation acceptance criteria.
Mandatory EMA Q&A 2018 periodic review of existing ADE certificates with updated literature search.
ADE assessment for biologics, biosimilars, monoclonal antibodies, and novel biological entities.
Cost-effective ADE certificate packages for facilities requiring assessments for multiple APIs simultaneously.
Yes — ADE (Acceptable Daily Exposure) and PDE (Permitted Daily Exposure) refer to the same health-based exposure limit concept. ADE is the ISPE/FDA terminology; PDE is the EMA terminology. FTI Advances issues certificates that satisfy both frameworks in a single document.
All ADE certificates from FTI Advances are signed by a qualified toxicologist with documented credentials in toxicology and pharmaceutical risk assessment — meeting EMA's requirement for a named expert with appropriate qualifications and experience.
Yes. FTI Advances prepares ADE certificates that simultaneously satisfy India's revised Schedule M, EMA Guideline EMA/CHMP/CVMP/SWP/169430/2012, WHO TRS 1033, and USFDA cleaning validation guidance — one document for all markets.
FTI Advances offers competitively priced ADE certificates with transparent pricing. Contact us for a quote based on your API type and quantity. Bulk discounts are available for 10+ molecules, and priority service options are available for urgent regulatory deadlines.
ADE certificates compliant with